TAT Products

Antibodies
TAT Antibody - BSA Free
TAT Antibody - BSA Free
NBP1-79286
Species: Rt
Applications: WB
Host: Rabbit Polyclonal
TAT Antibody - BSA Free
TAT Antibody - BSA Free
NBP2-95202
Species: Hu, Mu, Rt
Applications: WB
Host: Rabbit Polyclonal
Formulation Catalog # Availability Price  
TAT Antibody
TAT Antibody
NBP3-32995
Species: Hu, Mu, Rt
Applications: WB
Host: Rabbit Polyclonal
Lysates
TAT Overexpression Lysate
TAT Overexpression Lysate
NBP2-09032
Species: Hu
Applications: WB

Description

The transcriptional transactivator (Tat) is a key regulatory protein of HIV. It is expressed early after the virus integrates into the cell, and stimulates the elongation of RNA polymerase II. It binds onto a sequence known as the TAR, or transactivator response element, located at the end of the HIV genetic chain. There, the tat protein helps assemble new copies of HIV. The tat protein-TAR complex speeds up the rate of viral reproduction by about a thousand times. If it is not present, the transcription process frequently stops short, and few functional HIV particles are produced. Tat is an important potential target for antiretrovirals and vaccine development. Transcriptional regulator that acts by binding to the trans-activating responsive sequence (TAR) RNA element and activates transcription initiation and/or elongation from the LTR promoter.

Bioinformatics

Entrez Mouse
Rat
Human
Uniprot Human
Human
Human
Product By Gene ID 6898
Alternate Names
  • EC 2.6.1.5
  • L-tyrosine:2-oxoglutarate aminotransferase
  • tyrosine aminotransferase
  • tyrosine aminotransferase, cytosolic

Related TAT Blog Posts

Check out the latest blog posts on TAT.
Understanding Transcription with RNA Polymerase II
RNA polymerase II is a large 12-subunit complex that synthesizes all mRNAs and several non-coding RNAs in eukaryotic cells. It is a DNA-dependent RNA polymerase enzyme that catalyzes transcription of DNA into RNA based on the four ribonucleoside triph...    Read more.
Methamphetamine with HIV induces mitochondrial dysfunction and neuronal injury through oxidative stress
By Jamshed Arslan, Pharm. D., PhD. December 1 is the World AIDS Day. Despite the combination antiretroviral therapy, 10-25% of Human Immunodeficiency Virus (HIV)-positive individuals report neurocognitive impairm...    Read more.
Read more TAT related blogs.